Pharmaceutical

Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3

LAVAL, QC / ACCESSWIRE / July 13, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) will release its second-quarter financial results…

12 months ago

CureVac Strengthens Ongoing Patent Litigations Bringing Additional Cases Under New Intellectual Property Rights

Cases in Germany and the U.S. broadened by asserting additional, new intellectual property rightsThree new intellectual property rights added to…

12 months ago

Moderna to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023

CAMBRIDGE, MA / ACCESSWIRE / July 13, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…

12 months ago

Scilex Holding Company Announces Results From Independent Market Research Study Conducted with Pain Specialists and HCPs Treating Post-Herpetic Neuralgia (PHN) Pain on ZTlido®

ZTlido® profile has been viewed as a leading prescription lidocaine patch by pain specialists. Based on the independent market research…

12 months ago

Lucy Scientific Discovery Inc. Taps Fortune 500 Veteran and Current Executive Chairman Richard Nanula as New CEO

Nanula former CFO at Amgen and The Walt Disney Corporation to Bring Significant Strategic Focus and Leadership to Lucy Scientific…

12 months ago

Skye Bioscience Receives Positive Safety Review for Final Cohort of Fully-Enrolled Phase 1 Study of SBI-100 Ophthalmic Emulsion

Skye preparing to start Phase 2a glaucoma clinical trial in Q3San Diego, California--(Newsfile Corp. - July 13, 2023) - Skye…

12 months ago

Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare

WASHINGTON--(BUSINESS WIRE)--#parkerhealth--Parker Health an innovative biotech company for electronic health records, hospital developer & management, and subscription-based health services, today…

12 months ago

Medexus Announces Preliminary Revenue for Fiscal Q1 2024

Preliminary estimates indicate revenue is expected to exceed US$31 million for fiscal quarter ended June 30, 2023Toronto, Ontario and Chicago,…

12 months ago

Rexis Biotech Announces Strategic Partnership With 3CHI & Wefunder Crowdfunding Equity Raise

DOVER, DE / ACCESSWIRE / July 11, 2023 / Rexis Biotech Inc. ("REXIS") is delighted to announce its continued growth…

12 months ago

Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023

Conference Call and Webcast Scheduled for 1:30 p.m. PTALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and…

12 months ago